236 related articles for article (PubMed ID: 29123517)
1. Neutrophils in Gliomas.
Massara M; Persico P; Bonavita O; Mollica Poeta V; Locati M; Simonelli M; Bonecchi R
Front Immunol; 2017; 8():1349. PubMed ID: 29123517
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
3. [Neutrophils in the tumor microenvironment-foes or friends?].
Jablonska J; Rist M; Lang S; Brandau S
HNO; 2020 Dec; 68(12):891-898. PubMed ID: 32910257
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy.
Zilio S; Serafini P
Vaccines (Basel); 2016 Sep; 4(3):. PubMed ID: 27618112
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression.
Felix K; Gaida MM
Int J Biol Sci; 2016; 12(3):302-13. PubMed ID: 26929737
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop.
Wu Y; Zhao Q; Peng C; Sun L; Li XF; Kuang DM
J Pathol; 2011 Nov; 225(3):438-47. PubMed ID: 21826665
[TBL] [Abstract][Full Text] [Related]
7. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils.
Scapini P; Bazzoni F; Cassatella MA
Immunol Lett; 2008 Feb; 116(1):1-6. PubMed ID: 18155301
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-derived cells of the brain and malignant gliomas: the double face of Janus.
Kushchayev SV; Kushchayeva YS; Wiener PC; Scheck AC; Badie B; Preul MC
World Neurosurg; 2014 Dec; 82(6):1171-86. PubMed ID: 23178919
[TBL] [Abstract][Full Text] [Related]
9. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
10. Cytokine therapy.
Ohno M; Natsume A; Wakabayashi T
Adv Exp Med Biol; 2012; 746():86-94. PubMed ID: 22639161
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils in cancer.
Treffers LW; Hiemstra IH; Kuijpers TW; van den Berg TK; Matlung HL
Immunol Rev; 2016 Sep; 273(1):312-28. PubMed ID: 27558343
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin A: magic bullet or Trojan horse?
Heineke MH; van Egmond M
Eur J Clin Invest; 2017 Feb; 47(2):184-192. PubMed ID: 28024097
[TBL] [Abstract][Full Text] [Related]
14. Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response.
Smith SJ; Ward JH; Tan C; Grundy RG; Rahman R
Oncotarget; 2015 Sep; 6(26):22191-205. PubMed ID: 26203665
[TBL] [Abstract][Full Text] [Related]
15. Regulation of calcium homeostasis in activated human neutrophils--potential targets for anti-inflammatory therapeutic strategies.
Tintinger GR; Anderson R; Ker JA
S Afr Med J; 2002 Dec; 92(12):990-6. PubMed ID: 12561417
[TBL] [Abstract][Full Text] [Related]
16. The role of regulatory T cells in malignant glioma.
Sonabend AM; Rolle CE; Lesniak MS
Anticancer Res; 2008; 28(2B):1143-50. PubMed ID: 18505050
[TBL] [Abstract][Full Text] [Related]
17. Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease.
Leon F; Smythies LE; Smith PD; Kelsall BL
Adv Exp Med Biol; 2006; 579():117-32. PubMed ID: 16620015
[TBL] [Abstract][Full Text] [Related]
18. Recent advances of dendritic cells (DCs)-based immunotherapy for malignant gliomas.
Cho DY; Lin SZ; Yang WK; Hsu DM; Lee HC; Lee WY; Liu SP
Cell Transplant; 2009; 18(9):977-83. PubMed ID: 19523342
[TBL] [Abstract][Full Text] [Related]
19. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
20. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.
Furumoto K; Soares L; Engleman EG; Merad M
J Clin Invest; 2004 Mar; 113(5):774-83. PubMed ID: 14991076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
